About EMR FX
Company Overview
EMR FX is an Australian forex broker established on 7 February 2018 and operating through the domain emrfx.com. The firm is registered in Australia and holds an Australian Financial Services Licence (AFSL) issued by the Australian Securities and Investments Commission (ASIC). Its licence authorises the provision of institutional forex execution via straight-through processing (STP), positioning the broker as a regulated entity in the retail forex space.
As an ASIC-regulated broker, EMR FX is subject to the regulatory standards of one of the world’s most respected financial watchdogs. This includes client money segregation, regular reporting, and compliance with the Australian Corporations Act. The broker’s Scam Risk Score of 20/100, as assessed by FXCanary, indicates a low-risk profile, though the score is partly based on the regulatory shield rather than extensive independent user feedback.
Regulatory Status
EMR FX reports regulation by ASIC under an Australian Financial Services Licence. Our cross-check of the public ASIC register confirms that the licence is current and covers the provision of forex execution services on an STP basis. This means the broker routes client orders directly to liquidity providers without dealing desk intervention, a model often associated with transparent pricing.
The ASIC licence number is not publicly listed in the known facts, but the regulator's oversight is a significant factor in the broker’s low risk score. ASIC does not offer compensation schemes like the FSCS in the UK or the SIPC in the US; however, it enforces strict capital adequacy and client fund handling requirements.
Platform and Instruments
Based on the limited available information, EMR FX likely offers retail forex trading via an STP execution model. The ASIC licence specifically mentions 'Inst Forex Execution (STP)', suggesting that the broker provides access to major, minor, and potentially exotic currency pairs. Without access to the official website, we cannot confirm the trading platforms (e.g., MetaTrader 4/5, cTrader) or the full range of CFD instruments such as indices, commodities, or cryptocurrencies.
The absence of detailed product information in public records is notable. Traders should verify the available instruments directly with the broker before committing capital. The institutional STP model indicates that the broker may cater to both retail and professional clients, but this remains unconfirmed.
Account Types and Funding
No account types, minimum deposits, or funding methods are specified in the known facts. Typical ASIC-regulated brokers offer standard, mini, or Islamic accounts, but EMR FX’s specific offerings are not documented here. Similarly, accepted payment methods (bank wire, credit card, e-wallets) are not known.
Prospective clients should consult the broker's website or contact support for up-to-date information on account requirements, spreads, commissions, and leverage limits. ASIC imposes leverage restrictions of up to 30:1 on retail forex accounts, which would apply to EMR FX unless the client qualifies as a wholesale investor.
Target Audience
EMR FX positions itself as a broker for traders seeking STP execution under ASIC regulation. Its registration in Australia and focus on institutional forex execution suggests it may appeal to both retail traders and semi-professional clients who value transparency and regulatory oversight. However, the lack of publicly available user reviews or third-party commentary makes it difficult to assess its reputation among real traders.
The broker is not suited for traders who require unregulated offshore leverage or who prioritise a wide range of educational resources, as none are evident from the known facts.
Risk Assessment
FXCanary’s risk assessment of 20/100 (low risk) is primarily supported by the broker’s ASIC regulation and Australia domicile. ASIC has a strong enforcement record and requires licensees to maintain minimum net tangible assets. However, the lack of independent reviews and limited public information are cautionary elements. The broker has been operational since 2018, which provides some track record, but the absence of performance data or client testimonials means traders should proceed with due diligence.
In summary, EMR FX is a regulated but low-profile broker. Its low risk score is encouraging, but the information vacuum around its services warrants a careful approach. Traders should verify all details directly with the broker and start with a small deposit if they choose to trade.
Overview compiled by FXCanary from regulatory records and public data. full EMR FX review